Phenobarbital市場：依適應症、劑型、通路和地區分類

Phenobarbital市場規模預計在 2025 年為 17.4 億美元，預計到 2032 年將達到 24.5 億美元，2025 年至 2032 年的年複合成長率為 5%。

Phenobarbital是一種用於治療和預防癲癇的藥物。它透過調節導致癲癇發作的腦內異常電活動來發揮作用。它屬於抗驚厥藥和鎮靜藥。當人們感到焦慮或緊張時，它也可以用來幫助人們放鬆或睡眠。此藥必須憑醫師處方箋購買。

長期服用此藥有風險，包括影響人體對某些營養素（如鈣、B 群維生素、葉酸和維生素 D）的利用和吸收。它還可能降低血液中磷酸鹽的含量，而磷酸鹽是一種對細胞正常功能至關重要的電解質。長期服用此藥也可能導致甲狀腺激素問題。

市場動態

Phenobarbital是治療癲癇和癲癇發作的常用藥物，眾所周知。它被認為是多種癲癇發作的第一線治療藥物，尤其是在資源匱乏的地區。該藥物有效阻止癲癇發作的能力推動了其市場需求和使用。

Phenobarbital市場受到安全性較高、副作用較少的替代抗癲癇藥物供應的限制。具有多種作用機制和適應症的新藥的開發，為癲癇和癲癇發作性疾病的治療增添了新的選擇。負責人可能會選擇配製這些新藥而非Phenobarbital，尤其是在限制副作用和藥物交互作用至關重要的情況下。

研究的主要特點

• 本報告對全球Phenobarbital市場進行了詳細分析，並以 2024 年為基準年，展示了預測期 2025-2032 的市場規模和年複合成長率（CAGR%）。
• 它還揭示了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
• 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數概述了全球Phenobarbital市場的主要企業。
• 本報告的見解可以幫助負責人和公司經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球Phenobarbital市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過全球Phenobarbital市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• 一致的機會圖（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
• 癲癇盛行率不斷上升
  • 限制因素
• 替代抗癲癇藥物的可用性
• 副作用和安全問題
  • 機會
• 新生兒癲癇發生率不斷上升
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 合併、收購和合作

第4章。全球Phenobarbital市場-冠狀病毒 (COVID-19) 大流行的影響

• COVID-19流行病學
• 供需側分析
• 經濟影響

5. 全球Phenobarbital市場（按適應症），2020 年至 2032 年

• 介紹
• 癲癇
• 新生兒癲癇

6. 2020 年至 2032 年全球Phenobarbital市場（以劑型分類）

• 介紹
• 錠劑
• 膠囊
• 注射

7. 2020 年至 2032 年全球Phenobarbital市場（依通路分類）

• 介紹
• 醫院藥房
• 零售藥局
• 網路藥局

8. 2020 年至 2032 年全球Phenobarbital市場（按地區）

• 介紹
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 印度
  • 中國
  • 日本
  • 澳洲
  • 東南亞國協
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 北非
  • 中部非洲
  • 南非

第9章 競爭態勢

• 公司簡介
  • Sanofi
  • Pfizer Inc
  • Novartis AG.
  • Lundbeck A/S
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals
  • Cipla Ltd.
  • Par Pharmaceutical
  • Analysts'Views

第 10 章 章節

• 參考
• 調查方法
• 關於出版商

Phenobarbital Market is estimated to be valued at USD 1.74 Bn in 2025 and is expected to reach USD 2.45 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.

Phenobarbital is a medicine which is used to treat or prevent seizures. It works by regulating the abnormal electrical activity in the brain that causes seizures. It is a class of medications called anticonvulsants and sedatives. It is also sometimes used for to help a person relax or sleep when he/she is anxious or nervous. This medication is available only with a doctor's prescription.

There is risk associated with the use of this medication if it is used for a long time. These include problems with how the body uses or absorbs certain nutrients (e.g., calcium, B vitamins, folic acid, and vitamin D). It can also lower the blood levels of phosphate, an electrolyte that is important for normal cell function. Long-term use of this medication can also cause problems with thyroid hormones.

Market Dynamics

Phenobarbital is well-known for its effectiveness in the management of epilepsy and seizure disorders. It is regarded as a first-line treatment for several types of seizures, especially in areas with limited resources. The drug's ability to effectively stop seizures fuels demand for and use of it on the market.

The market for phenobarbital is constrained by the availability of substitute anti-epileptic medications with enhanced safety profiles and fewer adverse effects. There are additional alternatives for treating epilepsy and seizure disorders which is due to the development of new drugs with various mechanisms of action and focused indications. Especially, in situations when limiting adverse effects or drug interactions is important, healthcare practitioners may choose to prescribe these newer medications over phenobarbital.

Key features of the study:

• This report provides an in-depth analysis of the global phenobarbital market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global phenobarbital market based on the following parameters - company highlights, product portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sanofi, Pfizer Inc., Novartis AG, H. Lundbeck A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Cipla Ltd., and Par Pharmaceutical
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global phenobarbital market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global phenobarbital market

Global Phenobarbital Market Detailed Segmentation:

• By Indication
  • Epilepsy
  • Neonatal Seizures
• By Dosage Form
  • Tablets
  • Capsules
  • Injectables
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Sanofi
  • Pfizer Inc.
  • Novartis AG
  • Lundbeck A/S
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Hikma Pharmaceuticals
  • Cipla Ltd.
  • Par Pharmaceutical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Indication
  • Market Snippet, By Dosage Form
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of epilepsy
  • Restraints
• Availability of alternative anti-epileptic Drugs
• Adverse effects and safety concerns
  • Opportunities
• Increasing prevalence of neonatal seizures
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions and Collaborations

4. Global Phenobarbital Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Phenobarbital Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Epilepsy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Neonatal Seizures
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

6. Global Phenobarbital Market, By Dosage Form, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Tablets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Capsules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Injectables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Phenobarbital Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

8. Global Phenobarbital Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • India
    • China
    • Japan
    • Australia
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032 (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020 - 2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032 (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novartis AG.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Lundbeck A/S
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Hikma Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Cipla Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Par Pharmaceutical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analysts' Views

10. Section

• References
• Research Methodology
• About us